{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Survival analysis with GNN and Cox Model\n",
    "In this notebook, we implement the whole pipeline to make survival analysis with Cox Model and GNN."
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Pipeline description\n",
    "0. Reading dataset, drop censored patients, and label patients.\n",
    "1. Build the graph to connect samples\n",
    "2. Train the GNN for binary survival classification (event / no event) to learn the patients embeddings\n",
    "3. Train the Cox Model with new patients embeddings to predict survival metrics."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from models.BuildGraph import BuildGraph"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 0. Reading dataset and drop censored patients\n",
    "We use the dataset from the following article : https://doi.org/10.1158/1078-0432.CCR-20-1163. We drop the non naive patients."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Anonymous ID</th>\n",
       "      <th>EGA ID</th>\n",
       "      <th>Tumour type</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Line of therapy</th>\n",
       "      <th>Immunotherapy regimen</th>\n",
       "      <th>Cohort</th>\n",
       "      <th>Reason for discontinuation</th>\n",
       "      <th>Best response</th>\n",
       "      <th>Age at advanced disease diagnosis</th>\n",
       "      <th>...</th>\n",
       "      <th>Alive_0</th>\n",
       "      <th>Time to progression (days)</th>\n",
       "      <th>Progression_1</th>\n",
       "      <th>Clinical benefit</th>\n",
       "      <th>CD8+ T cell score</th>\n",
       "      <th>Exome mut per mb</th>\n",
       "      <th>Genome mut per mb</th>\n",
       "      <th>CD274 expression</th>\n",
       "      <th>M1M2 expression</th>\n",
       "      <th>Lymph related</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>14891</td>\n",
       "      <td>EGAD00001001961</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>8</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Mixed</td>\n",
       "      <td>45</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>179</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.351869</td>\n",
       "      <td>11.095310</td>\n",
       "      <td>23.0729</td>\n",
       "      <td>4.1689</td>\n",
       "      <td>55.51575</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>18624</td>\n",
       "      <td>EGAD00001002047</td>\n",
       "      <td>AECA</td>\n",
       "      <td>F</td>\n",
       "      <td>10</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>47</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>148</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.071464</td>\n",
       "      <td>3.876336</td>\n",
       "      <td>5.4552</td>\n",
       "      <td>0.7910</td>\n",
       "      <td>9.32352</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>21392</td>\n",
       "      <td>EGAD00001002544</td>\n",
       "      <td>OV</td>\n",
       "      <td>F</td>\n",
       "      <td>6</td>\n",
       "      <td>Monalizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>57</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>79</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.040394</td>\n",
       "      <td>2.415688</td>\n",
       "      <td>4.1274</td>\n",
       "      <td>4.0377</td>\n",
       "      <td>50.12008</td>\n",
       "      <td>Lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>21516</td>\n",
       "      <td>EGAD00001002546</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Ipilimumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>29</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.052774</td>\n",
       "      <td>6.235845</td>\n",
       "      <td>11.4871</td>\n",
       "      <td>0.6006</td>\n",
       "      <td>1.58550</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>22186</td>\n",
       "      <td>EGAD00001001966</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>52</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>80</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.009323</td>\n",
       "      <td>4.606660</td>\n",
       "      <td>7.1503</td>\n",
       "      <td>1.8234</td>\n",
       "      <td>38.42695</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>39280</td>\n",
       "      <td>EGAD00001004933</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Physician Assessed SD</td>\n",
       "      <td>60</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>401</td>\n",
       "      <td>0</td>\n",
       "      <td>DCB</td>\n",
       "      <td>0.695396</td>\n",
       "      <td>84.998501</td>\n",
       "      <td>96.4079</td>\n",
       "      <td>8.4768</td>\n",
       "      <td>86.62561</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>37899</td>\n",
       "      <td>EGAD00001005838</td>\n",
       "      <td>CHOL</td>\n",
       "      <td>F</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Physician assessed PR</td>\n",
       "      <td>38</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>96</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.818233</td>\n",
       "      <td>2.247151</td>\n",
       "      <td>2.7416</td>\n",
       "      <td>11.2704</td>\n",
       "      <td>47.97376</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>37775</td>\n",
       "      <td>EGAD00001004934</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>M</td>\n",
       "      <td>1</td>\n",
       "      <td>Avelumab/OX40 agonist PF-04518600</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>69</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>69</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.018982</td>\n",
       "      <td>3.848247</td>\n",
       "      <td>5.8036</td>\n",
       "      <td>8.7136</td>\n",
       "      <td>5.13403</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>38313</td>\n",
       "      <td>EGAD00001005844</td>\n",
       "      <td>ACC</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Avelumab/Debio1143 (SMAC mimetic)</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Partial response</td>\n",
       "      <td>34</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>51</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>5.617878</td>\n",
       "      <td>7.7940</td>\n",
       "      <td>0.0688</td>\n",
       "      <td>0.51364</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>38207</td>\n",
       "      <td>EGAD00001005850</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>1</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>50</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>104</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.110416</td>\n",
       "      <td>33.763449</td>\n",
       "      <td>53.2769</td>\n",
       "      <td>23.8818</td>\n",
       "      <td>11.22022</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>82 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Anonymous ID           EGA ID Tumour type Sex Line of therapy   \n",
       "0          14891  EGAD00001001961        LUNG   F               8  \\\n",
       "1          18624  EGAD00001002047        AECA   F              10   \n",
       "2          21392  EGAD00001002544          OV   F               6   \n",
       "3          21516  EGAD00001002546        SKCM   F               3   \n",
       "4          22186  EGAD00001001966        LUNG   F               4   \n",
       "..           ...              ...         ...  ..             ...   \n",
       "92         39280  EGAD00001004933        LUNG   M               2   \n",
       "94         37899  EGAD00001005838        CHOL   F               2   \n",
       "95         37775  EGAD00001004934        HNSC   M               1   \n",
       "96         38313  EGAD00001005844         ACC   F               3   \n",
       "97         38207  EGAD00001005850        LUNG   F               1   \n",
       "\n",
       "                Immunotherapy regimen Cohort Reason for discontinuation   \n",
       "0                           Nivolumab  Naive                Progression  \\\n",
       "1                           Nivolumab  Naive                Progression   \n",
       "2                         Monalizumab  Naive                Progression   \n",
       "3                          Ipilimumab  Naive                      Death   \n",
       "4                        Atezolizumab  Naive                Progression   \n",
       "..                                ...    ...                        ...   \n",
       "92                      Pembrolizumab  Naive                   Toxicity   \n",
       "94                          Nivolumab  Naive                      Death   \n",
       "95  Avelumab/OX40 agonist PF-04518600  Naive                Progression   \n",
       "96  Avelumab/Debio1143 (SMAC mimetic)  Naive                   Toxicity   \n",
       "97                      Pembrolizumab  Naive                Progression   \n",
       "\n",
       "            Best response  Age at advanced disease diagnosis  ...  Alive_0   \n",
       "0                   Mixed                                 45  ...        1  \\\n",
       "1          Stable disease                                 47  ...        1   \n",
       "2   Physician assessed SD                                 57  ...        1   \n",
       "3           Not evaluable                                 29  ...        1   \n",
       "4          Stable disease                                 52  ...        1   \n",
       "..                    ...                                ...  ...      ...   \n",
       "92  Physician Assessed SD                                 60  ...        1   \n",
       "94  Physician assessed PR                                 38  ...        1   \n",
       "95         Stable disease                                 69  ...        1   \n",
       "96       Partial response                                 34  ...        1   \n",
       "97  Physician assessed SD                                 50  ...        0   \n",
       "\n",
       "    Time to progression (days)  Progression_1  Clinical benefit   \n",
       "0                          179              1               NCB  \\\n",
       "1                          148              1               NCB   \n",
       "2                           79              1               NCB   \n",
       "3                           11              0               NCB   \n",
       "4                           80              1               NCB   \n",
       "..                         ...            ...               ...   \n",
       "92                         401              0               DCB   \n",
       "94                          96              0               NCB   \n",
       "95                          69              1               NCB   \n",
       "96                          51              1               NCB   \n",
       "97                         104              1               NCB   \n",
       "\n",
       "   CD8+ T cell score  Exome mut per mb  Genome mut per mb  CD274 expression   \n",
       "0           0.351869         11.095310            23.0729            4.1689  \\\n",
       "1           0.071464          3.876336             5.4552            0.7910   \n",
       "2           0.040394          2.415688             4.1274            4.0377   \n",
       "3           0.052774          6.235845            11.4871            0.6006   \n",
       "4           0.009323          4.606660             7.1503            1.8234   \n",
       "..               ...               ...                ...               ...   \n",
       "92          0.695396         84.998501            96.4079            8.4768   \n",
       "94          0.818233          2.247151             2.7416           11.2704   \n",
       "95          0.018982          3.848247             5.8036            8.7136   \n",
       "96          0.000000          5.617878             7.7940            0.0688   \n",
       "97          0.110416         33.763449            53.2769           23.8818   \n",
       "\n",
       "    M1M2 expression      Lymph related  \n",
       "0          55.51575  Non-lymph related  \n",
       "1           9.32352  Non-lymph related  \n",
       "2          50.12008      Lymph related  \n",
       "3           1.58550  Non-lymph related  \n",
       "4          38.42695  Non-lymph related  \n",
       "..              ...                ...  \n",
       "92         86.62561  Non-lymph related  \n",
       "94         47.97376  Non-lymph related  \n",
       "95          5.13403  Non-lymph related  \n",
       "96          0.51364  Non-lymph related  \n",
       "97         11.22022  Non-lymph related  \n",
       "\n",
       "[82 rows x 21 columns]"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_excel('data/Supplemental-table1.xlsx')\n",
    "\n",
    "# Delete non naive patients\n",
    "df = df.loc[df[\"Cohort\"] == \"Naive\"]\n",
    "\n",
    "df"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Delete censored patients\n",
    "In statistics, some patients can have non faithful metrics, because of leaving the study for example. In our context, we want to drop patients which have not experienced an event (status = 0) and where the time of event is less than a given time t (which represents the time when we look at). Indeed, it might represent a precocious leaving of the patient ; what happened between the time of leaving and the time t when we look at ?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "def drop_censored_patients(df: pd.DataFrame, status_name: str, time_name: str, t: float)->pd.DataFrame:\n",
    "    \"\"\" \n",
    "    Delete censored patients from the initial dataframe. A censored patient is a patient with status = 0 and time_event < t.\n",
    "\n",
    "    ### Parameters :\n",
    "    - df : the dataframe to update\n",
    "    - status_name : the name of the status event column in the dataframe\n",
    "    - time_name : the name of the time event column in the dataframe\n",
    "    - t : the time when we look at (threshold).\n",
    "\n",
    "    ### Returns :\n",
    "    The dataframe without censored patients.\n",
    "    \"\"\"\n",
    "\n",
    "    # Get index of to drop patients\n",
    "    to_drop = df.index[np.where((df[status_name] == 0) & (df[time_name]<t))[0]]\n",
    "    print(f\"{to_drop.shape[0]} patients censored deleted\")\n",
    "\n",
    "    # Update dataframe\n",
    "    df_non_censored = df.drop(to_drop,axis=0)\n",
    "\n",
    "    return df_non_censored"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6 patients censored deleted\n",
      "1 patients censored deleted\n"
     ]
    }
   ],
   "source": [
    "## TTP (Time To Progression)\n",
    "t_ttp = np.median(df[\"Time to progression (days)\"].to_numpy())\n",
    "df_ttp_non_censored = drop_censored_patients(df, \"Progression_1\", \"Time to progression (days)\", t_ttp)\n",
    "\n",
    "## OS (Overall survival)\n",
    "t_os = np.median(df[\"Overall survival (days)\"].to_numpy())\n",
    "df_os_non_censored = drop_censored_patients(df, \"Alive_0\", \"Overall survival (days)\", t_os)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Label patients for future classification\n",
    "Now, we want to create a label column to split event occured patients and no event occured patients : \n",
    "- status = 1 and time < t : class 1 (the event occured)\n",
    "- status = 1 and time > t : class 0 (the event has not occured yet at the time when we look at. The event will occur later)\n",
    "- status = 0 and time > t : class 0 (the event has not occured at the time when we look at)\n",
    "- status = 0 and time < t : censored patients, we already dropped these patients.\n",
    "\n",
    "Because we already dropped censored patients, we can see that we just have to test if time < t. If yes, we label 1, otherwise, we label 0."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "def label_patients(df: pd.DataFrame, time_name: str, t: float)->pd.DataFrame:\n",
    "    \"\"\" \n",
    "    Create new column in dataframe with event label depending on status, time and t values.\n",
    "\n",
    "    ### Parameters :\n",
    "    - df : the dataframe to update\n",
    "    - status_name : the name of the status event column in the dataframe\n",
    "    - time_name : the name of the time event column in the dataframe\n",
    "    - t : the time when we look at (threshold).\n",
    "\n",
    "    ### Returns :\n",
    "    The dataframe with an extra label column.\n",
    "    \"\"\"\n",
    "    \n",
    "    # We test if time < t (1 if yes, 0 otherwise)\n",
    "    df[\"event_occured\"] = np.where(df[time_name]<t, 1, 0)\n",
    "    \n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "## TTP :\n",
    "df_ttp_non_censored = label_patients(df_ttp_non_censored, \"Time to progression (days)\",t_ttp)\n",
    "\n",
    "## OS :\n",
    "df_os_non_censored = label_patients(df_os_non_censored, \"Overall survival (days)\",t_os)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Build the graph to connect patients\n",
    "For now, we gather patients with the same tumour type, and, for each tumour type, all patients are inter-connected."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "## TTP :\n",
    "buildgraph_ttp = BuildGraph(df_ttp_non_censored)\n",
    "\n",
    "## OS :\n",
    "buildgraph_os = BuildGraph(df_os_non_censored)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Create adjacency matrix\n",
    "If 2 patients have the same tumour type, we put 1 if the corresponding case in adjacency matrix. Otherwise, we put 0."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "## TTP :\n",
    "buildgraph_ttp.compute_adjacency_matrix(\"Tumour type\")\n",
    "\n",
    "## OS :\n",
    "buildgraph_os.compute_adjacency_matrix(\"Tumour type\")"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Create the graph from adjacency matrix\n",
    "Each node of the graph contains its features and its label. Then, with the adjacency matrix, we connect nodes. The resulting graph is under networkx format. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Name of the features for each node\n",
    "features_name = [\"CD8+ T cell score\",\"Exome mut per mb\"]\n",
    "\n",
    "# Name of the label for each node\n",
    "label_name = \"event_occured\"\n",
    "\n",
    "## TTP :\n",
    "buildgraph_ttp.create_graph(features_name, label_name)\n",
    "\n",
    "## OS :\n",
    "buildgraph_os.create_graph(features_name, label_name)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Vizualize the graph\n",
    "Let's see what our graphs look like."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x700 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x700 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "## TTP :\n",
    "buildgraph_ttp.show_graph(\"TTP graph\",\"ttp-graph.png\")\n",
    "\n",
    "## OS :\n",
    "buildgraph_os.show_graph(\"OS graph\",\"os-graph.png\")"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
